Lawlor TH

Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients

Publish date: September 1, 2007

Infliximab is a chimeric immunoglobulin G1κ monoclonal antibody against tumor necrosis factor α (TNF-α), a proinflammatory cytok...